Purchase Order HHSN271201800097P

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Labcorp Early Development Laboratories Inc., a for-profit organization, for mass balance studies. The contract has a potential value of $416,126.00 and a completion date of December 16, 2020. This contract was not set aside. Labcorp Early Development Laboratories Inc. is a subsidiary of Laboratory...

This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings, to provide laboratory testing and quality assurance services for the LMB-100 drug product. The objective is to conduct the required testing and assays to support the Investigational New Drug (IND) application for LMB-100, an anti-mesothelin immunotoxin being developed by NCI's Laboratory of Molecular...

This firm fixed-price delivery order was awarded by the Northeast Area of a civilian federal agency to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings, for dietary supplement analysis services. The $102,212.96 contract has a period of performance through September 28, 2017 and was not set aside for small businesses. Labcorp Early Development Laboratories Inc. is a for-profit organization that provides a range of laboratory testing and...

This is a firm fixed-price delivery order contract awarded by the Northeast Area division of a civilian federal agency to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings. The $94,239.14 contract is for the provision of laboratory testing and analytical services, including stability testing, potency and safety assays, polyclonal antibody production, pharmacokinetics testing, compositional analysis, and other services to support the work of...

This is a $19,000 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Frontage Laboratories, Inc., a full-service contract research organization (CRO). The contract is for the synthesis of SAMT-247 and an analog compound. Frontage Laboratories has previously supported NIDDK and the National Center for Advancing Translational Sciences through various federal contracts, providing services such as pharmacokinetic testing, in...

This is a $247,150.00 firm fixed price purchase order awarded by the Department of Health and Human Services' Food and Drug Administration to Impact Analytical Inc., a for-profit limited liability company. The contract is for the development of a validated analytical method and screening for diethylene glycol/ethylene glycol in over-the-counter children's cough syrup. The contract has a completion date of March 28, 2025. Impact Analytical Inc. is a full-service contract analytical laboratory...

This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The $46,133.68 award is for "DOSE RESPONSE ANALYSES OF MONTELUKAST TARGETS" and has a completion date of September 29, 2025. Eurofins Panlabs, Inc. has received numerous federal contract awards from agencies such as the NIH, EPA, and VA to provide a range of research and development services,...

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Qualtech Laboratories, Inc., a self-certified small disadvantaged business, woman-owned small business, and for-profit organization. The contract, valued at $99,750.00, is for the analysis of corticotropin products using the United States Pharmacopeia (USP) rat-based bioassay. The contract does not have a set-aside designation and has an ultimate completion date of October 31, 2015. Qualtech...

This firm fixed-price purchase order was awarded by the Department of Health and Human Services' (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Pharmaron, Inc., a minority-owned for-profit organization, to conduct testing of compounds for the blocking of cardiac ion channels. The period of performance is from August 7, 2020 to December 31, 2021, with a potential value of $24,795.00. The work is being performed in Louisville, Kentucky....

This contract was awarded to Labcorp Early Development Laboratories Inc., a for-profit subsidiary of Laboratory Corporation of America Holdings, to provide a range of laboratory testing and analytical services to federal agencies such as the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, with a ceiling value of $3,314,000.00 and an ultimate completion date of September 29, 2000. The...